The publication follows hard on the heels of detailed efficacy results from the randomized and open-label phases of its companion study in gay and bisexual men and trans women, HPTN 083, which were announced during last month’s Conference on Retroviruses and Opportunistic Infections.
A detailed analysis of HIV infections seen in HPTN 084, the study comparing the effectiveness of injectable versus oral HIV pre-exposure prophylaxis (PrEP) in cisgender women, has been published in the Journal of Infectious Diseases. Headline findings were reported in November 2020 when the study was stopped early due to the clearly superior effectiveness of the injections.
The data shows that for cis women injected PrEP is more effective than oral PrEP, due to it being easier to adhere to, than the pills.
Read the full article on aidsmap.com.